-
Zhittaya finalizing applications to FDA to begin treating subjects with PD
Zhittaya has decided to move forward with a study with their drug in ALS subjects. Outcomes from an ALS clinical trial, could provide valuable information to advance heir Parkinson’s disease clinical trials.
See their latest webinar from 10/20/2018 at: https://www.youtube.com/watch?v=zELPN3e1_VE
For PD specific info on Parkinson’s and the clinical Trials, it begins at 32:33
Here is a link to keep informed and/or request to participate in trials:
https://sites.google.com/view/pdzhittya/sign-up-with-zhittya
What do you think of their approach? Does it hold hope for you?
Sorry, there were no replies found.
Log in to reply.